Skip to main content
Premium Trial:

Request an Annual Quote

Quantum-Si Acquires Semiconductor Firm Majelac Technologies

NEW YORK – Proteomics firm Quantum-Si said Tuesday that it has acquired semiconductor company Majelac Technologies.

Quantum-Si said the acquisition secured Garnet Valley, Pennsylvania-based Majelac's semiconductor chip assembly and packaging capabilities and would help bolster the supply chain for its chip-based biosensing platform and support its commercialization efforts.

Founded by Jonathan Rothberg, who also founded next-generation sequencing company Ion Torrent, Guilford, Connecticut-based Quantum-Si aims to similarly apply semiconductor chip technology to protein sequencing, allowing for single-molecule analysis of proteins, including post-translational modifications. Ultimately, the company plans to apply its technology to molecules other than proteins, including metabolites and nucleic acids.

"The acquisition of Majelac brings chip assembly and packaging capabilities in-house, and it also accelerates our ability to scale up operations to meet demand and support future chip designs," Quantum-Si CEO John Stark said in a statement. "This strategic acquisition and vertical integration allow us to secure our supply chain to meet customer demand amidst existing global semiconductor supply chain issues."

Financial and other terms of the acquisition were not disclosed.

The Scan

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government. CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.

Genome Research Papers on Craniosynostosis, Macaque Retrotransposition, More

In Genome Research this week: structural variants in craniosynostosis, LINE-1 activity in rhesus macaque brain, and more.

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.